DIVERSITY AND DISTRIBUTIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1099451, encodeId=eb6a1099451f7, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099452, encodeId=191c109945259, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860000, encodeId=4a45860000c8, content=审稿速度:2.0 经验分享：听了4月27日aibin zhan老师分享的ddi期刊投稿介绍和后才发现，自己还是19年比较幸运的8个中国学者之一（82篇投稿接受8篇），可想而知10%的中国学者接受率。在此分享一下我的投稿过程供各位参考（ps: 希望大家多多引用https://doi.org/10.1111/ddi.13018）。 submitted 2019-07-09 initial checking 2019-7-11 under review 2019-07-11 awating ed recommandation 2019-8-27 awating se decision 2019-9-3 major revision 2019-9-3 revision submission 2019-10-29 under review 2019-10-30 awating ed recommandation 2019-11-26 awaiting se decision 2019-12-3 accept 2019-12-3 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Wed Apr 29 12:44:40 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544109, encodeId=84b354410985, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

审稿人会不会通过我提供的关键词检索创新性？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099451, encodeId=eb6a1099451f7, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099452, encodeId=191c109945259, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860000, encodeId=4a45860000c8, content=审稿速度:2.0 经验分享：听了4月27日aibin zhan老师分享的ddi期刊投稿介绍和后才发现，自己还是19年比较幸运的8个中国学者之一（82篇投稿接受8篇），可想而知10%的中国学者接受率。在此分享一下我的投稿过程供各位参考（ps: 希望大家多多引用https://doi.org/10.1111/ddi.13018）。 submitted 2019-07-09 initial checking 2019-7-11 under review 2019-07-11 awating ed recommandation 2019-8-27 awating se decision 2019-9-3 major revision 2019-9-3 revision submission 2019-10-29 under review 2019-10-30 awating ed recommandation 2019-11-26 awaiting se decision 2019-12-3 accept 2019-12-3 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Wed Apr 29 12:44:40 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544109, encodeId=84b354410985, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-27 MS68862005

审稿人怎么利用关键词审稿？

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1099451, encodeId=eb6a1099451f7, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099452, encodeId=191c109945259, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860000, encodeId=4a45860000c8, content=审稿速度:2.0 经验分享：听了4月27日aibin zhan老师分享的ddi期刊投稿介绍和后才发现，自己还是19年比较幸运的8个中国学者之一（82篇投稿接受8篇），可想而知10%的中国学者接受率。在此分享一下我的投稿过程供各位参考（ps: 希望大家多多引用https://doi.org/10.1111/ddi.13018）。 submitted 2019-07-09 initial checking 2019-7-11 under review 2019-07-11 awating ed recommandation 2019-8-27 awating se decision 2019-9-3 major revision 2019-9-3 revision submission 2019-10-29 under review 2019-10-30 awating ed recommandation 2019-11-26 awaiting se decision 2019-12-3 accept 2019-12-3 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Wed Apr 29 12:44:40 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544109, encodeId=84b354410985, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2020-04-29 ms5619336576777824

审稿速度:2.0
经验分享：听了4月27日aibin zhan老师分享的ddi期刊投稿介绍和后才发现，自己还是19年比较幸运的8个中国学者之一（82篇投稿接受8篇），可想而知10%的中国学者接受率。在此分享一下我的投稿过程供各位参考（ps: 希望大家多多引用https://doi.org/10.1111/ddi.13018）。
submitted 2019-07-09
initial checking 2019-7-11
under review 2019-07-11
awating ed recommandation 2019-8-27
awating se decision 2019-9-3
major revision 2019-9-3
revision submission 2019-10-29
under review 2019-10-30
awating ed recommandation 2019-11-26
awaiting se decision 2019-12-3
accept 2019-12-3

56 0

[GetPortalCommentsPageByObjectIdResponse(id=1099451, encodeId=eb6a1099451f7, content=审稿人会不会通过我提供的关键词检索创新性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099452, encodeId=191c109945259, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860000, encodeId=4a45860000c8, content=审稿速度:2.0 经验分享：听了4月27日aibin zhan老师分享的ddi期刊投稿介绍和后才发现，自己还是19年比较幸运的8个中国学者之一（82篇投稿接受8篇），可想而知10%的中国学者接受率。在此分享一下我的投稿过程供各位参考（ps: 希望大家多多引用https://doi.org/10.1111/ddi.13018）。 submitted 2019-07-09 initial checking 2019-7-11 under review 2019-07-11 awating ed recommandation 2019-8-27 awating se decision 2019-9-3 major revision 2019-9-3 revision submission 2019-10-29 under review 2019-10-30 awating ed recommandation 2019-11-26 awaiting se decision 2019-12-3 accept 2019-12-3 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Wed Apr 29 12:44:40 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544109, encodeId=84b354410985, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

249 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务